Donovan Joanne M. 4
4 · Edgewise Therapeutics, Inc. · Filed Sep 24, 2024
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2024-09-20$28.29/sh−7,162$202,603→ 14,538 total
Footnotes (2)
- [F1]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $28.29, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Includes 1,803 shares purchased on May 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.